Search results
Displaying 1 - 10 of 35 results
- Benefits and risks of taking anti-seizure medicines for epilepsy, mental health, or pain
-
Safe use of opioids data collection and reporting workbook (manual data capture)
Spreadsheet template for manual data capture, for the safe use of opioids data collection and reporting.
-
Acetylcysteine for the treatment of paracetamol overdose and toxicity – 2-bag dosing guidance
New dosing guidance for acetylcysteine for the treatment of paracetamol overdose and toxicity issued in January 2019.
-
Safety Signal: Changes to the labelling of Bicillin LA®
Following international practice, the name and strength description for Bicillin LA® has been changed. The expression of the name will now be benzathine benzylpenicillin tetrahydrate. The expression of product strength will now be 1,200,000 units/2.3
-
Safe use of opioids measurement: frequently asked questions
Frequently asked questions about measurement for the safe use of opioids.
-
Gary's story: a consumer perspective on taking warfarin
This is the story of Gary Edwards, a 60-year-old builder from Waitarere Beach, who ended up on Warfarin after a cardiac event.
-
Pharmac leaflet explaining medicine brand changes
This leaflet from Pharmac explains why brand names, appearance and packaging of your medicines may have changed.
-
Opioid implementation package
This package outlines the next steps and what the options are to make a significant difference in opioid-induced adverse drug events.
-
Patient information - Help us to help you
A leaflet about medicines safety for patients coming into hospital.
-
Consumer flyer: Ask your pharmacist for advice about your medicines
Consumer flyer: help with your medicines is available – ask your pharmacist for advice.